We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.
The outline terms agreed between DHSC and the Association of the British Pharmaceutical Industry (ABPI) for the voluntary scheme.
Intellectual property research publications commissioned by the Intellectual Property Office (IPO) covering trade marks and brands.
Examines factors influencing the 5.19% growth in branded medicines under the Pharmaceutical Price Regulation Scheme (PPRS) in 2013 to 2014.
Impact assessment to permit a 0.2 percent increase in the list price of branded medicines supplied by manufactures and suppliers under the statutory scheme from January 2012.
The second annual review of the regulations relating to the statutory scheme for branded medicines pricing.
This consultation seeks views on proposals to update the statutory scheme to control the cost of branded health service medicines.
Find out about applying for the Spirit Drinks Verification Scheme, how to submit brand information, fees and making sure your production process is compliant.
This series brings together all documents relating to Energy Efficiency Strategy.
Product Safety Report for FQDVM-branded Red Plush Toy (Model BRB-2029) presenting a high risk of suffocation.
These bulletins provide a more detailed analysis of Northern Ireland's performance on the 2021 Anholt Ipsos Nation Brands Index, across the six dimensions of national competence: Exports; Governance; Culture; People; Tourism; and Immigration and Investment.
Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.
The first annual review of the regulations relating to the statutory scheme for branded medicines pricing.
Provides information on how the Pharmaceutical Price Regulation Scheme (PPRS) is controlling spend on branded medicines in the NHS.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.